This article explores the limitations of SPOS, and provides an overview of chemoenzymatic ligation, its mechanism, and comparative advantages in siRNA and sgRNA synthesis.
Hongeneとともに、RNAの最前線へ — 最先端の科学、技術革新、業界動向をお届けします。
Mar 18, 2025David Butler, CTO
This article explores the limitations of SPOS, and provides an overview of chemoenzymatic ligation, its mechanism, and comparative advantages in siRNA and sgRNA synthesis.